Bio-Path Holdings, Inc. (BPTH)
0.0257
0.00 (0.00%)
USD |
OTCM |
Sep 09, 16:00
Bio-Path Holdings Shareholders Equity (Quarterly) : -9.687M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.687M |
| March 31, 2026 | -8.486M |
| December 31, 2025 | -8.221M |
| September 30, 2025 | -8.004M |
| June 30, 2025 | -7.158M |
| March 31, 2025 | -2.589M |
| December 31, 2024 | 0.154M |
| September 30, 2024 | -0.712M |
| June 30, 2024 | 1.291M |
| March 31, 2024 | -2.625M |
| December 31, 2023 | 0.441M |
| September 30, 2023 | 2.525M |
| June 30, 2023 | 5.043M |
| March 31, 2023 | 9.107M |
| December 31, 2022 | 14.17M |
| September 30, 2022 | 16.20M |
| June 30, 2022 | 19.52M |
| March 31, 2022 | 22.32M |
| December 31, 2021 | 25.46M |
| September 30, 2021 | 29.35M |
| June 30, 2021 | 29.75M |
| March 31, 2021 | 31.37M |
| December 31, 2020 | 15.07M |
| September 30, 2020 | 13.19M |
| June 30, 2020 | 16.01M |
| Date | Value |
|---|---|
| March 31, 2020 | 17.93M |
| December 31, 2019 | 21.09M |
| September 30, 2019 | 16.02M |
| June 30, 2019 | 17.91M |
| March 31, 2019 | 20.14M |
| December 31, 2018 | 1.218M |
| September 30, 2018 | 2.988M |
| June 30, 2018 | 4.737M |
| March 31, 2018 | 6.275M |
| December 31, 2017 | 8.067M |
| September 30, 2017 | 6.549M |
| June 30, 2017 | 8.855M |
| March 31, 2017 | 8.092M |
| December 31, 2016 | 8.24M |
| September 30, 2016 | 9.377M |
| June 30, 2016 | 6.327M |
| March 31, 2016 | 8.046M |
| December 31, 2015 | 9.818M |
| September 30, 2015 | 11.19M |
| June 30, 2015 | 12.60M |
| March 31, 2015 | 13.63M |
| December 31, 2014 | 14.92M |
| September 30, 2014 | 16.00M |
| June 30, 2014 | 17.03M |
| March 31, 2014 | 18.18M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.006M |
| Total Liabilities (Quarterly) | 9.693M |
| Debt to Equity Ratio | -0.0537 |
| Current Ratio | 0.0006 |
| Net Debt Paydown Yield | -1.73% |